◼ Archived
Business
🔮 fades
All eyes on data on Biogen’s tau therapy
Biogen's experimental Alzheimer's drug diranersen has sparked industry-wide attention with new Phase 2 data presented at AAIC.
Celia
1 trends tracked about this subject — the full history, oldest to newest below.